What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?
CLL update from ICML17: Current treatment and future directions for patients
Clinical evidence supporting rituximab
Won Seog Kim
Can biosimilars ensure access to drugs for everyone?
Biosimilars in oncology: EHA 2017 session on rituximab